减肥手术对肥胖个体内皮质功能和结构的影响:一项前性研究
Xiao Li1, Shuo Wang2, Lianjie Sun3
1Zhongshan Hospital, Shanghai, China.
Obesity surgery
|July 9, 2025
概括
代谢和减肥手术 (MBS) 在12个月内有效减少腹部肥胖,改善内皮功能和血管健康. 这种减肥显著提高了流媒扩张 (FMD),这是心血管健康的关键指标.
科学领域:
- 心血管科学 心血管科学
- 代谢健康 代谢健康
- 手术创新 在外科创新.
背景情况:
- 肥胖指数与内皮功能障碍有关.
- 特别是腹部肥胖症,与血管内皮功能有着强烈的负相关性.
研究的目的:
- 调查肥胖指数与内皮功能障碍之间的关联.
- 评估代谢和减肥手术 (MBS) 诱导的体重减轻对血管内皮功能和结构重塑的时间效应.
主要方法:
- 在MBS之前和12个月后,对224个人进行了纵向研究.
- 使用身体质量指数 (BMI) 和度指数 (CI) 量化肥胖症.
- 通过流媒扩张 (FMD) 评估内皮功能,通过 Carotid Intima-Media 厚度 (cIMT) 评估血管结构.
主要成果:
- 术前分析显示了口病和BMI之间的负相关性,由度指数 (CI) 放大.
- 在12个月内,MBS导致CI下降,口病增加;cIMT最初保持不变.
- 糖尿病患者在MBS后表现出口病恢复,血糖降低和胰岛素抵抗.
结论:
- 腹部肥胖与显著的内皮功能障碍有关.
- 在12个月内,MBS促进了持续的减肥,并改善了内皮功能.
- MBS有效降低心血管疾病的风险因素,特别是在糖尿病患者中.
相关概念视频
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324


